TLDR:
SmarterDx, a NYC-based clinical AI company, raised $50M in Series B funding led by Transformation Capital. The company plans to use the funds to accelerate product innovation and market expansion to benefit hospitals and health systems.
SmarterDx, a clinical AI company specializing in revenue integrity and care quality, raised $50M in Series B funding to accelerate product innovation and market expansion. The funding round, which brought total funding to $71M to date, was led by Transformation Capital, with participation from Bessemer Venture Partners, Flare Capital Partners, and Floodgate Fund.
The company, led by CEO Dr. Michael Gao, uses AI to understand each patient’s clinical journey and helps hospitals improve revenue integrity. SmarterDx focuses on empowering clinical documentation integrity and coding teams to capture a more accurate patient picture, allowing providers to focus on patient care. The funding will be used to add new clinical and financial data integrations and refine proprietary algorithms to identify revenue and quality opportunities for customers. Additionally, the company plans to expand its market reach to benefit hospitals and health systems.
